«Raf Kinases

Below is an extended Raf Kinases patents listing. Click here to return to the Raf Kinases main in depth entry.

Patents :
US Patent No.	Title
6566581	Transgenic non-human mammals with an oncogenic mutant of Raf-1 gene
6987119	Imidazol-2-carboxamide derivatives as raf kinase inhibitors
6998391	Method for treating diseases associated with abnormal kinase activity
7001905	Substituted diarylamines as MEK inhibitors
7019033	2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
7026336	Compounds
7030119	Method for treating chronic pain using MEK inhibitors
7041453	Molecular constructs and methods of use for detection of biochemical reactions
7067532	Substituted quinolines as antitumor agents
7071216	Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
7078438	N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
6960614	Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
6916846	Coumermycin analogs as chemical dimerizers of chimeric proteins
6891066	N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
6638945	Quinoline derivatives as inhibitors of MEK enzymes
6670348	Methods and compositions for destruction of selected proteins
6723830	Short peptides which selectively modulate the activity of protein kinases
6750217	Benzenesulfonamide derivatives and their use as MEK inhibitors
6770778	N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
6803360	Compositions and methods for reducing radiation and drug resistance in cells
6809106	Quinoline derivatives as inhibitors of MEK enzymes
6821963	4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
6833436	Short peptides which selectively modulate the activity of serine/threonine kinases
6835749	Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
7141576	Cancer treatment method
7160915	N-methyl-substituted benzamidazoles
7320864	Methods of using molecular constructs for detection of biochemical reactions
7329670	Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
7351834	.omega.-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
7354945	2-oxadiazolechromone derivatives
7368542	Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
7371763	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
7375105	Pyridine substituted furan derivatives as Raf kinase inhibitors
7378233	BRAF mutation T1796A in thyroid cancers
7378421	Chromenone derivatives
7402583	Substituted quinolines as antitumor agents
7307100	2-Benzoylchromone derivatives
7297694	Pyridylfurans and pyrroles as Raf kinase inhibitors
7297693	Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors
7169816	4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
7173135	Substituted 3-cyanoquinolines as MEK inhibitors
7173136	3-Cyano-quinoline derivatives
7199137	Imidazole derivatives as Raf kinase inhibitors
7235576	Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
7235658	Imidazol derivatives as Raf kinase inhibitors
7250434	CCK-1 receptor modulators
7253184	4-Substituted quinolines as antitumor agents
7273877	5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives
7282500	Imidazole-2-carboxamide derivatives as Raf kinase inhibitors
7411001	Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.